You are here

Relmada

Relmada rails against depression data both 'implausible' and 'unplausible' in latest phase 3 flunk

Fierce Biotech

Thu, 12/8/22 - 10:20 am

clinical trials

Relmada’s MDD Drug Misses Endpoint, Marred by “Paradoxical Results”

BioSpace

Thu, 10/13/22 - 11:45 pm

major depressive disorder

clinical trials

Fourth-quarter data for the little guys

EP Vantage

Mon, 10/3/22 - 10:01 am

Key data catalysts for the industry’s small players

EP Vantage

Fri, 07/1/22 - 09:35 am

Intercept Pharma

atopic dermatitis

short bowel syndrome

Assembly Biosciences

Significant readouts for small players

EP Vantage

Thu, 03/31/22 - 10:22 am

clinical trials

SAGE Therapeutics